Boothbay Fund Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Boothbay Fund Management’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-63,089	Closed	-$1.26M	–	2799
2022 Q3	$1.26M	Buy	+63,089	New	+$832K	0.03%	771

Boothbay Fund Management's FMTX Position: Q4 2022 in Review

Boothbay Fund Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 63,089 shares — an estimated $1.26M sold.

Boothbay Fund Management first reported a position in FMTX in Q3 2022 and held it in 1 quarter. The position peaked at $1.26M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Boothbay Fund Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Boothbay Fund Management sold 63,089 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $1.26M.
Boothbay Fund Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
Boothbay Fund Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $1.26M in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Boothbay Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.